gamma H2AX Anticorps
(gamma Histone Variant H2AX (GAMMA-H2AX))
antibodies-online.com est synonyme de produits de recherche de haute qualité. Cherchez, trouvez et commandez des outils avec des données de validation étendues, des images, des références. Notre service clientèle scientifique est toujours à votre disposition si vous avez des questions sur la sélection ou l'application de nos produits.
gamma H2AX recommandé Anticorps
- (8)
Dernières publications sur nos produits gamma H2AX
: "The p97-Ataxin 3 complex regulates homeostasis of the DNA damage response E3 ubiquitin ligase RNF8." dans: The EMBO journal, Vol. 38, Issue 21, pp. e102361, (2020) (PubMed).: "BRCA1 Haploinsufficiency Is Masked by RNF168-Mediated Chromatin Ubiquitylation." dans: Molecular cell, Vol. 73, Issue 6, pp. 1267-1281.e7, (2019) (PubMed).
: "Methods to Quantify the NF-κB Pathway During Senescence." dans: Methods in molecular biology (Clifton, N.J.), Vol. 1896, pp. 231-250, (2019) (PubMed).
: "Mouse Models of Accelerated Cellular Senescence." dans: Methods in molecular biology (Clifton, N.J.), Vol. 1896, pp. 203-230, (2019) (PubMed).
: "p53-TP53-Induced Glycolysis Regulator Mediated Glycolytic Suppression Attenuates DNA Damage and Genomic Instability in Fanconi Anemia Hematopoietic Stem Cells." dans: Stem cells (Dayton, Ohio), Vol. 37, Issue 7, pp. 937-947, (2019) (PubMed).
: "DNA Replication Vulnerabilities Render Ovarian Cancer Cells Sensitive to Poly(ADP-Ribose) Glycohydrolase Inhibitors." dans: Cancer cell, Vol. 35, Issue 3, pp. 519-533.e8, (2019) (PubMed).
: "PARP inhibitor re‑sensitizes Adriamycin resistant leukemia cells through DNA damage and apoptosis." dans: Molecular medicine reports, Vol. 19, Issue 1, pp. 75-84, (2019) (PubMed).
: "GSK-3β protects fetal oocytes from premature death via modulating TAp63 expression in mice." dans: BMC biology, Vol. 17, Issue 1, pp. 23, (2019) (PubMed).
: "Reprogramming of Meiotic Chromatin Architecture during Spermatogenesis." dans: Molecular cell, Vol. 73, Issue 3, pp. 547-561.e6, (2019) (PubMed).
: "Targeting NAD+ Metabolism as Interventions for Mitochondrial Disease." dans: Scientific reports, Vol. 9, Issue 1, pp. 3073, (2019) (PubMed).